Arthrosurface receives 510(k) clearance for Patellofemoral WaveKahuna Arthroplasty System

Friday, June 29 2018

Arthrosurface receives 510(k) clearance for Patellofemoral WaveKahuna Arthroplasty System

Arthrosurface receives 510(k) clearance for Patellofemoral WaveKahuna Arthroplasty System June 29,
Arthrosurface Inc. announced it has received 510(k) clearance from the FDA to market its Patellofemoral WaveKahuna Arthroplasty System.
The Patellofemoral (PF) WaveKahuna Arthroplasty System is an extension of the products in the company’s HemiCAP Patellofemoral & PF Wave Systems product family, all of which are cleared and commercially marketed, according to a company press release.
The PF WaveKahuna system is designed to restore the articular surface geometry of the patella and femoral trochlea in order to help maintain the patient’s native knee anatomy. According to the release, the system also helps patellofemoral tracking and stability with its trochlear geometry and extended lateral aspect.
“As a market leader in patellofemoral arthroplasty, we are very excited to round out our line with the PF WaveKahuna System. The larger implants will allow a surgeon to choose from a wide range of size offerings to better serve the patient’s needs and allow them to maintain their quality of life,” Shane Shankle , Arthrosurface vice president of U.S. sales, said in the press release.
Reference:
Arthrosurface Inc. announced it has received 510(k) clearance from the FDA to market its Patellofemoral WaveKahuna Arthroplasty System.
The Patellofemoral (PF) WaveKahuna Arthroplasty System is an extension of the products in the company’s HemiCAP Patellofemoral & PF Wave Systems product family, all of which are cleared and commercially marketed, according to a company press release.
The PF WaveKahuna system is designed to restore the articular surface geometry of the patella and femoral trochlea in order to help maintain the patient’s native knee anatomy. According to the release, the system also helps patellofemoral tracking and stability with its trochlear geometry and extended lateral aspect.
“As a market leader in patellofemoral arthroplasty, we are very excited to round out our line with the PF WaveKahuna System. The larger implants will allow a surgeon to choose from a wide range of size offerings to better serve the patient’s needs and allow them to maintain their quality of life,” Shane Shankle , Arthrosurface vice president of U.S. sales, said in the press release.
Reference: